Quantum量子訊息有限公司
← 最新全球產業報告

Prothrombin Complex Concentrates Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-06-24 · 254 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 1,253.4 Mn
2033 年預估規模
USD 2,473.7 Mn
年複合成長率 CAGR
10.2%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-06-24頁數 254報告編號 CMI4647

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Prothrombin Complex Concentrates Market, By Type (3-Factor PCC, 4-Factor PCC), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, Others), By End User (Hospital, Ambulatory Surgical Centres, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Prothrombin complex concentrates (PCCs) are highly purified concentrate prepared from blood plasma with hemostatic activity contain four vitamin K-dependent clotting factors (F) (II (prothrombin), VII, IX and X), for replacement therapy in patients with congenital or acquired deficiencies. Moreover, in several European countries, prothrombin complex concentrates are also used in the management of massive peri- and postoperative bleeding. Market Dynamics Global Prothrombin Complex Concentrates Market is expected to show significant growth, owing to increasing approval of product. For instance, in 2013, the U.S Food and Drug Administration (FDA) accepted Octapharma USA’s Biological License Application (BLA) for octaplex 4-Factor PCC, for indication of reversal of anticoagulation therapy in patients undergoing vitamin K antagonist therapy with the need for urgent surgery or invasive procedures Key features of the study • This report provides in-depth analysis of the global prothrombin complex concentrates market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global prothrombin complex concentrates market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Octapharma AG, Nihon Pharmaceutical Co Ltd, Grifols S.A., CSL Behring GmbH, Kedrion Biopharma Inc., Shire Plc, China Biologic Products Holdings, Inc., and Sanquin • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global prothrombin complex concentrates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prothrombin complex concentrates market Market Segmentation • By Type (Revenue, USD Mn, 2021-2033) o 3-Factor PCC o 4-Factor PCC • By Application (Revenue, USD Mn, 2021-2033) o Acquired Coagulation Factor Deficiency o Congenital Coagulation Factor Deficiency o Others • By End User (Revenue, USD Mn, 2021-2033) o Hospital o Ambulatory Surgical Centres o Others • By Region (Revenue, USD Mn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Octapharma AG o Nihon Pharmaceutical Co. Ltd. o Grifols S.A. o CSL Behring GmbH o Kedrion Biopharma Inc. o Shire Plc o China Biologic Products Holdings, Inc. o Sanquin
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type  Market Snapshot, By Application  Market Snapshot, By End User  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Product Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Prothrombin Complex Concentrates Market, By Type, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o 3-Factor PCC  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o 4-Factor PCC  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 5. Global Prothrombin Complex Concentrates Market, By Application, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Acquired Coagulation Factor Deficiency  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Congenital Coagulation Factor Deficiency  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 6. Global Prothrombin Complex Concentrates Market, By End User, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Hospital  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Ambulatory Surgical Centres  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 7. Global Prothrombin Complex Concentrates Market, By Region, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Octapharma AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Nihon Pharmaceutical Co. Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Grifols S.A. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  CSL Behring GmbH o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Kedrion Biopharma Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Shire Plc o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  China Biologic Products Holdings, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Sanquin o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 9. Section o References o Research Methodology o About Us

提及公司

Octapharma AGNihon Pharmaceutical Co. Ltd.Grifols S.A.CSL Behring GmbHKedrion Biopharma Inc.Shire PlcChina Biologic Products Holdings, Inc.Sanquin

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們